Gene Query: SNRPD1

Dataset Description Geneva Score
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 26.52
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 26.52
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 25.77
RIG-I and MDA5 fRIP during KSHV lytic reactivation 23.61
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 23.45
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 21.77
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 21.73
hnRNP C is a key regulator of protein synthesis in mitosis 21.65
Gene expression changes caused by KRAS in MCF-10A 21.44
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 21.42
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 21.08
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 19.99
Co-transcriptional loading of RNA export factors shapes the human transcriptome 19.27
RNAseq of HEK293 cells after Chtop knockdown 19.27
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles 18.89
Single-nucleotide-resolution mapping of HBV promoters using CAGE 18.87
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 18.84
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 18.77
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 18.77
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 18.74
MYCi361 regulates MYC target genes 18.63
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 18.48
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 18.28
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 18.19
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 18.19
The landscape of alternative splicing in aggressive prostate cancers 18.17
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 18.0
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 17.98
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 17.94
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 17.53
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 17.4
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 17.33
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 17.27
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 16.82
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 16.16
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 16.11
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 16.02
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 16.02
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 15.48
Gene expression analysis of dengue-infected cells 15.37
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 15.3
Unique features and clinical importance of acute alloreactive immune responses 15.27
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 15.26
BCL11B 15.22
RNA-seq of resting and activated CD4+ T cells +-JQ1 15.22
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 15.19
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 15.19
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 15.11
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 15.09
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 14.98
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 14.98
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 14.96
Global analysis of enhancer targets: Mosaic-seq 14.84
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 14.69
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 14.69
Developmental stage specific chromosome architecture in human erythroid cells 14.63
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 14.63
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 14.55
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 14.55
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 14.39
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 14.37
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 14.28
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 14.27
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 14.18
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 14.0
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 13.98
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 13.95
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 13.89
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 13.89
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 13.89
Transcriptome analysis of Zika infected neural stem cells 13.8
Zika infected neural stem cells 13.8
RNA-Seq with and without RNase treatment in PCa cell lines 13.76
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 13.76
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 13.4
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 13.33
Ultracentifugation and nanoscale deterministic lateral displacement (nanoDLD) of samples for exRNA analysis 13.32
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 13.3
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 13.21
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 13.1
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 13.09
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 13.09
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 13.0
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 12.83
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 12.78
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 12.7
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 12.69
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 12.63
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 12.63
Comparative Transcriptomics of Triple Negative Breast Cancer Stem Cells and Differentiated Tumor Cells Identifies Teneurin-4 as a Potential Therapeutic Target 12.55
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 12.45
Effect of FGF13 depletion on the H460 cell line 12.31
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 12.29
miRNAs affected by antagomiR-17 treatment 12.28
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 12.18
RNA-seq analysis of RALD iPSCs after in vitro differentiation 12.14
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 12.11
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 11.95
HNF1A deficiency impairs β-cell fate, granule maturation and function 11.87
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 11.71
TCF7L1 knockdown in pancreatic cancer 11.68
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 11.62
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 11.6
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 11.51
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation 11.39
Novel Targeting of Transcription and Metabolism in Glioblastoma 11.38
Ribosomal footprinting of CN34-Parental and CN34-LM1a 11.35
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 11.26
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 11.26
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 11.17
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 11.17
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 11.15
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 11.12
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 11.09
Sensing self and nonself circular RNAs 11.08
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 11.04
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 10.96
3’ Uridylation Expands miRNA Target Repertoire 10.94
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 10.91
Transcriptomic profiling of human coronary artery endothelial cells under laminar shear stress (LS), oscillatory shear stress (OS) and static culture (ST) 10.9
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 10.9
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 10.9
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 10.89
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 10.89
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 10.86
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 10.84
A549 cells and MSR-A549 cells 10.84
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 10.84
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 10.82
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 10.75
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 10.75
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 10.7
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 10.68
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 10.68
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 10.56
Human HAP1 cells before and after nutrient deprivation 10.56
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 10.46
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 10.42
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 10.37
Differentially expressed vascular development genes for iPSC-ECs from CDI 10.33
Paxillin regulates genomic networks in prostate cancer [LNCaP] 10.31
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  10.3
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 10.26
Transcriptome of activated human and mouse MAIT cells 10.17
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 10.13
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 10.09
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 10.05
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 10.02
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 10.01
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 9.99
Altering cancer transcriptomes using epigenomic inhibitors 9.99
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 9.98
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 9.97
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 9.97
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 9.95
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 9.95
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 9.95
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 9.84
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 9.83
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 9.79
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 9.79
Transcriptomic analyssis following EHMT1/2 inhibition 9.79
RNA-seq of YB5 cells treated with Proscillaridin A 9.78
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 9.76
mRNA expression profile of Lymphocytes 9.71
RNA-seq analysis of differentiating human erythroblasts 9.7
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 9.69
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 9.63
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 9.63
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 9.58
Disruption of the exocyst induces podocyte loss and dysfunction 9.56
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 9.55
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 9.55
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 9.52
Nucleoporin-mediated regulation of cell identity genes 9.5
Generating Patterned Kidney Organoids for Studying Development and Diseases 9.47
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 9.47
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches 9.44
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 9.42
Human neutrophil genome during PMA- and E. coli encounter-induced activation 9.42
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 9.42
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 9.4
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 9.39
Maturation of human iNSCs 9.38
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 9.32
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 9.25
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 9.24
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 9.22
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 9.17
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 9.17
Identification of HOXB13 target genes responsive to BET inhibitors 9.12
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 9.12
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 9.07
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 9.06
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 9.06
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 9.02
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 9.01
A role for ZNF598 in post-transcriptional gene regulation 9.0
Transcription control by the ENL YEATS domain in acute leukemia 8.97
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 8.97
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 8.94
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 8.93
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 8.92
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 8.92
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 8.92
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 8.92
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 8.89
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 8.87
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 8.84
Transcriptional profiles of normal human mature B cells 8.81
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 8.78
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 8.78
DRB/GRO-Seq -/+ UV 8.77
Ribosomal footprinting of MDA-Parental and MDA-LM2 8.76
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 8.74
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 8.74
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 8.72
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 8.72
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 8.72
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 8.71
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 8.71
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 8.7
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 8.7
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 8.7
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 8.69
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 8.69
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 8.61
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 8.58
Identification of Sin3B regulated genes during quiescence 8.55
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 8.55
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 8.49
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 8.47
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 8.41
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 8.41
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 8.4
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 8.36
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 8.35
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 8.34
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 8.34
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 8.34
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 8.29
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 8.28
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 8.26
Total RNA-seq in ALL-SIL upon JQ1 inhibition 8.25
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 8.22
Regulation of protein translation during mitosis 8.19
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 8.19
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 8.19
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 8.17
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 8.16
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 8.12
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 8.09
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 8.09
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 8.04
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 8.04
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 8.04
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 8.04
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 8.03
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 8.0
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 7.95
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 7.91
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 7.88
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 7.84
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 7.84
A map of gene expression in neutrophil-like cell lines 7.77
RNA sequencing of primary human platelets and in vitro cell lines 7.67
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 7.63
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 7.55
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 7.54
Heterozygous mutations in SMARCA2 lead to impaired neurogenesis due to global retargeting of SMARCA4 7.52
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 7.5
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 7.47
mTOR hyperactivation in Down Syndrome mediates deficits in autophagy induction, autophagosome formation, and mitophagy 7.46
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 7.44
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 7.44
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 7.4
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 7.38
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 7.36
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 7.34
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 7.33
RNA polymerase in pre-B-ALL cell lines 7.31
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 7.3
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 7.3
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 7.3
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 7.29
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 7.28
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 7.24
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 7.24
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 7.19
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 7.09
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 7.03
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 6.89
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 6.83
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 6.82
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 6.82
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 6.79
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 6.75
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 6.75
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 6.75
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 6.75
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 6.75
Human cells contain natural double-stranded RNAs with potential regulatory capacity 6.67
Primary Human B-cell Temporal Response to CD40L Stimulation 6.63
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 6.51
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 6.5
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 6.5
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 6.49
nELAVL HITS-CLIP in Alzheimer's Disease patients 6.49
Transcriptome analysis of kidney organoids 6.46
Hepatocyte maturation 6.44
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 6.33
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 6.29
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 6.21
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 6.21
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 6.2
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 6.2
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 6.14
RNA-seq of RKO cells with cTAZ KO or putback 6.06
Co-regulation of splicing by Rbfox1 and hnRNP M 6.05
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 6.05
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 6.03
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 6.0
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 5.93
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 5.88
An integrative analysis of non-coding regulatory DNA variations associated with autism 5.87
Integrin signaling regulates YAP/TAZ to control skin homeostasis 5.78
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 5.76
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 5.74
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 5.73
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 5.73
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype 5.72
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [RNA-seq] 5.72
Capturing the Interactome of Newly Transcribed RNA 5.62
Capturing the Interactome of Newly Transcribed RNA (RICK) 5.62
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 5.59
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 5.59
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 5.56
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 5.52
Gene expression profile in breast cancer cells 5.48
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 5.48
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 5.45
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 5.43
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 5.43
RNA sequencing of mechanically strained NHEKs and control NHEKs 5.35
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 5.3
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 5.19
Expression by CD133+ cells isolated from the adult human exocrine pancreas 5.14
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 5.12
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 5.06
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 5.06
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 5.03
The transcriptomic landscape of MAIT cell development in the thymus (C006 RNAseq data set) 5.03
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 4.91
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 4.86
6mer seed toxicity in tumour suppressive microRNAs 4.78
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 4.7
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 4.69
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 4.63
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 4.62
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 4.61
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 4.59
Derivation and differentiation of haploid human embryonic stem cells [RNA-Seq 1] 4.51
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 4.5
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 4.28
Ribosome profiling upon inhibition of eIF4A 4.27
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 4.23
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 4.23
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 4.22
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 4.22
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 4.19
RNA seq with AML (NB4) cells upon FTO inhibition 4.11
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 4.08
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 4.08
Gene expression profiling in metabolically heterogeneous human lung tumors 3.99
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 3.95
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 3.91
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 3.9
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 3.9
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 3.9
Single-cell analysis of human kidney organoids 3.9
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 3.83
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 3.82
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 3.8
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 3.78
A single-cell transcriptome atlas of the human pancreas 3.77
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 3.76
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 3.73
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 3.7
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 3.69
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 3.68
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 3.68
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 3.62
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 3.55
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 3.55
Effect of BB608 on Gene Expression in HNSCC Cell Line 3.36
Solid phase chemistry to covalently and reversibly capture thiolated RNA 3.21
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 3.18
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 3.16
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 3.16
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 3.16
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 3.16
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 3.13
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 3.09
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 3.08
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 3.07
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 3.06
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 3.06
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 2.95
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 2.93
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 2.89
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 2.88
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 2.75
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 2.73
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 2.71
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 2.71
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 2.7
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 2.66
Identification of miRNA signatures during the differentiation of hESCs into retinal pigment epithelial cells 2.63
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 2.62
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 2.6
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 2.57
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 2.57
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 2.56
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 2.55
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 2.54
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 2.39
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 2.28
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 2.27
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 2.22
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 2.17
RNA-Seq analysis of human colorectal cancer with liver metastasis 2.16
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 2.1
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 2.1
CDK12 mediated transcriptional regulation in U2OS cells 2.02
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 1.98
Comparative Analysis of Cas9 Activators Across Multiple Species 1.94
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 1.92
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 1.92
6mer seed toxicity in viral microRNAs 1.91
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 1.87
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 1.81
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 1.74
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 1.65
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 1.64
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 1.64
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 1.64
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 1.62
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 1.6
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 1.58
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 1.52
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 1.49
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 1.43
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 1.42
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 1.37
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 1.36
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 1.36
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 1.35
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 1.21
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 1.13
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 1.11
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 1.07
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 1.07
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 1.07
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 1.06
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 1.06
Transcriptome profiling of A2M treated A549 Cell Line Samples 1.05
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 1.0
SF3B1 Degron knockdown RNA-seq 0.99
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 0.9
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.88
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.88
The role of the Calcium-Sensing receptor in colorectal cancer 0.77
Function and hormonal regulation of GATA3 in human first trimester placentation 0.75
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier [human] 0.75
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier 0.75
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.72
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 0.71
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 0.66
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 0.6
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 0.59
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 0.59
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 0.58
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.54
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.51
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 0.44
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 0.43
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 0.42
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 0.38
Low-Cell-Number, Single-Tube Amplification (STA) of RNAs Revealed miRNA Changes from Pluripotency to Endothelium 0.37
Determining mRNA half-lives on a transcriptome-wide scale 0.34
IMP3 regulated gene expression in breast cancer cells 0.32
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 0.27
Impact on erythroid progenitor type on erythroid differntiation 0.27
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 0.2
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.17
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.16
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 0.09
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.06
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.06
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation